PolarCool

PolarCool AB (publ) signs agreement with Västerås IK in HockeyAllsvenskan

Thu, Nov 21, 2019 08:00 CET

PolarCool has signed an agreement with Västerås IK for one (1) PolarCap® System. The hockey club will use PolarCap® System for the remainder of the current season. Västerås IK will thus become the reference team in HockeyAllsvenskan and the collaboration is expected to be the starting point for a broader establishment in second tier league in Sweden. Västerås IK Sports Director Patrik Zetterberg comments; - Västerås IK regards concussions as a serious matter and for us it is important to take care of our players, not the least by actively engaging us and working together to

PolarCool AB (publ) establishes PolarCap® System in the German hockey league through a deal with Adler Mannheim

Tue, Nov 19, 2019 07:30 CET

PolarCool has signed an agreement on a (1) PolarCap® System with the German hockey club Adler Mannheim, which plays in Germany's top tier ice hockey division, DEL. Adler Mannheim will evaluate PolarCap® System during the remainder of the current season. Adler Mannheim will thus become a reference team in Germany and PolarCool believes that the collaboration serves as good potential for wider establishment in Germany. PolarCool's CEO Christian Strand comments; - In our ambition to establish ourselves in several of the European hockey markets, this first agreement with a German

PolarCool AB (publ) signs an agreement with Zurich SC Lions in the Swiss hockey league

Mon, Nov 18, 2019 08:00 CET

PolarCool AB (publ) has signed a cooperation agreement with Zurich SC Lions in the Swiss ice hockey league National League A, which is the top tier in the Swiss league system. Zurich SC Lions will evaluate PolarCap® System until the end of the current season. Zürich SC Lions will thus become a reference team in the Swiss league, in a market where PolarCool (publ) also has good hopes of developing the business. PolarCool's Erik Andersson comments; - The fact that Dr. Gery Büsser, a very reputable doctor in this area, now chooses to include the use of PolarCap® System in his

PolarCool AB (publ) has submitted a joint application for Eurostars grant, together with its partner ABCDx and Lund University, which could generate 1 MEUR for the consortium

Wed, Oct 09, 2019 12:46 CET

PolarCool, ABCDx SA, and Lund University have submitted a joint application for EU grants through the Eurostars program. The application could generate up to 1 million Euro in EU grants for the consortium. Eurostars is an EU program which supports international innovative projects led by research and development performing small- and medium-sized enterprises (SMEs). The program has EUR 57 million annually available for co-financing the development of new products and technologies. The consortium will develop and commercialize PolarTBICheck™,

PolarCool AB (publ) signs partnership agreement with ABCDx for the diagnostic tool TBICheck ™ covering the Nordic market

Wed, Sep 11, 2019 08:00 CET

PolarCool AB has entered into a partnership agreement with the Switzerland based company ABCDx SA for evaluation and potential sales rights in the Nordic region for TBICheck ™, a portable device for detection of mild traumatic brain injury. The partnership agreement provides the opportunity for PolarCool to obtain an exclusive distributor agreement for the sale of TBICheck ™ in the Nordic sports market, and a non-exclusive distributor agreement in the Nordic healthcare market. PolarCool could thereby widen its product portfolio with a unique offering that has good potential within sports

PolarCool AB (publ) presents improved results from the pilot study with SHL and HockeyAllsvenskan

Fri, Sep 06, 2019 07:46 CET

In collaboration with the Swedish Hockey League (SHL) and HockeyAllsvenskan, PolarCool conducted a study during the past three seasons, wherein PolarCap® System has been evaluated for the treatment of concussion. A total of 12 teams participated in the study; the intervention group has used the PolarCap® System and the control group has consisted of players who have not received the treatment. The purpose of the clinical study has been to measure symptom relief, in order to examine how quickly the player progresses through a mandatory rehab program until return to play. The program is a

Matz Johansson new CEO at PolarCool AB (publ)

Thu, Sep 05, 2019 08:00 CET

PolarCool's Board of Directors has appointed Matz Johansson as new CEO. He succeeds Iman Ziai who will continue as CFO and head of Investor Relations. PolarCool's Chairman of the Board, Mats Forsman, comments; - The Board is very pleased to be able to appoint Matz Johansson as new CEO. Matz has a broad background, not the least from the medical device field, which is important to us. He is a respected leader and the right type of businessman to develop our offering to create strong relationships with both national and international customers. The Board has a long-term strategy

Share